URAC Congressional Briefing: MedWatch invited to Spotlight the Power of Accreditation in Chronic Disease Management
Lake Mary, FL – On Tuesday, July 15, from 10:30 to 11:30 a.m., MedWatch’s President and CEO, Sally-Ann Polson, will join a distinguished panel at the URAC Congressional Briefing in the Rayburn House Office Building in Washington, D.C. The event, titled “Accreditation 101: Improving Health Care Quality, From Chronic Care to Telehealth,” will explore the importance of accreditation and how Chronic Disease Management enhances the quality, access, and cost-efficiency of care.
While the primary audience is Congressional staffers focused on healthcare policy, the briefing is also open to the public and will be moderated by Dr. Shawn Griffin, MD, URAC’s President and CEO. Other panelists include Jennifer Richards, PhD, PharmD, JD, URAC’s Senior Director, Product Development and Tejal Ashok Raichura, MHA, Children’s National Hospital’s Director of Telemedicine.
MedWatch: Leading the Charge in Accredited Chronic Care
URAC accredited in Disease Management since 2007 and a long-standing advocate for quality-driven healthcare, MedWatch brings a unique perspective to the conversation. Polson will share how accreditation has been instrumental in MedWatch’s approach to Chronic Disease Management, ensuring that care is not only clinically sound, but also strategically aligned with the needs of self-funded employers and their members.
“Accreditation is more than a seal; it’s a commitment to accountability, innovation, and measurable outcomes,” says Polson. “At MedWatch, it’s how we deliver smarter, more effective care that improves lives and lowers costs.”
Accreditation: A Catalyst for Better Outcomes
For self-funded plans, Chronic Disease Management is both a health and financial priority. Accreditation helps ensure that programs like MedWatch’s meet rigorous, evidence-based standards: driving consistency, early intervention, and personalized care. This results in fewer hospitalizations, better medication adherence, and improved patient engagement.
Data-Driven, Patient-Centered, and Cost-Effective
Accredited programs are also built to evolve. MedWatch leverages accreditation to continuously refine its care models, integrate new technologies, and use data to close gaps in care. This proactive approach not only enhances patient outcomes but also delivers significant cost savings for employers.
Join the Conversation
MedWatch’s participation in this URAC Congressional Briefing underscores the vital role of accreditation in transforming chronic care delivery. Whether you’re shaping policy or managing a health plan, this session offers valuable insights into how accreditation can elevate care quality and financial performance.
About MedWatch
Since 1988, MedWatch has been an industry leader in providing effective population health and medical management solutions that deliver improved clinical and financial outcomes for plans and plan members.
MedWatch services include URAC Accredited Health Utilization Management, Case Management, and Disease Management, while Pathways Concierge has become the industry standard for white-glove member advocacy and support. With over 30 core and ancillary services, MedWatch provides clients with a comprehensive offering of proven solutions to effectively identify, manage and mitigate risk.
MedWatch’s proprietary technology and commitment to client information and data security is validated through their successful completion of the SOC 2 Type 2 audit.
To learn more, visit urmedwatch.com.
For inquiries, please contact: sales@urmedwatch.com or 321.249.9179